|
The Pharmaceutical
Journal Vol 267 No 7169 p526 |
|
The Frankenstein touch |
The Frankenstein touch
Mrs Shelleys first and most celebrated novel was written to pass the tedious time during a wet summer in Switzerland where she, her husband Percy, their friend Byron, and Byrons physician, John Polidori, were isolated by the weather during a holiday. The frightful creature fashioned by Dr Frankenstein from a corpse and brought to life through the energy of a lightning flash became the emblem of the hazard of playing with the elements. The moral of the story was that any creator of a living being has to face squarely the moral responsibility both for the behaviour of his creation and for the consequences of such behaviour as it impacts upon society. The modern attitude towards genetic modification has tended to gloss over the important issue that scientists who put their theories into action must always shoulder responsibility before, during and after research and development. They must accept that any outcome, however intentional or unintentional, is their personal responsibility. The parallel lies with the story of Prometheus, the classical Titan who, contrary to the will of Zeus, stole fire because he thought it might prove of benefit to mankind, and was made to suffer as a consequence. The main worry over the Frankenstein experiment, writes Segal, is the secretive, self-centred and ultimately destructive arrogance of the experimenter. The inventors indifference towards the shape of the creation and how it might function once released from the laboratory and loosed upon the world is the crux of the matter. In the event, Mary Shelley insists, Frankensteins monster turned out to have a more acute sense of guilt than does its creator, who demonstrates greater arrogance. In 1818 there were intriguing reports of electrical charges being used to activate parts of corpses and produce the illusion of life that really did not exist. There was speculation, indeed, over the potential of chemistry and electricity between them to create new life from inanimate matter. Such concerns have been revived today, and it will not be wise for the engineers of genetic recombinations to overlook the Frankenstein story as they go about their experiments. |
Home | Journals | News | Notice-board | Search | Jobs Classifieds | Site
Map | Contact us
©The Pharmaceutical Journal